Searched for: school:SOM
Department/Unit:Population Health
Lessons learned from the 1-hour post-load glucose level during the OGTT - Current screening recommendations for dysglycemia should be revised
Bergman, Michael; Jagannathan, Ram; Buysschaert, Martin; Pareek, Manan; Olsen, Michael H; Nilsson, Peter M; Medina, José Luis; Roth, Jesse; Chetrit, Angela; Groop, Leif; Dankner, Rachel
This perspective covers a novel area of research describing the inadequacies of current approaches for diagnosing dysglycemia and proposes that the 1-hour post-load glucose level during the 75 gram OGTT may serve as a novel biomarker to detect dysglycemia earlier than currently recommended screening criteria for glucose disorders. Considerable evidence suggests that a 1-hour post-load plasma glucose value >155 mg/dl (8.6 mmol/l) may identify individuals with reduced β-cell function prior to progressing to prediabetes and diabetes and is highly predictive of those likely to progress to diabetes more than the HbA1cor 2-hour post-load glucose values. An elevated 1-hour post-load glucose level was a better predictor of type 2 diabetes than isolated 2- hour post-load levels in Indian, Japanese, and Israeli and Nordic populations. Furthermore, epidemiological studies have shown that a 1-hour PG >155 mg/dl (8.6 mmol/l) predicted progression to diabetes as well as increased risk for microvascular disease and mortality when the 2-hour level was < 140 mg/dl (7.8 mmol/l). The risk of myocardial infarction or fatal ischemic heart disease was also greater among subjects with elevated 1-hour glucose levels as were risks of retinopathy and peripheral vascular complications in a Swedish cohort. The authors believe that the considerable evidence base supports redefining current screening and diagnostic recommendations with the 1-hour post-load level. Measurement of the 1-hour PG level would increase the likelihood of identifying a larger, high-risk group with the additional practical advantage of potentially replacing the conventional 2-hour OGTT making it more acceptable in a clinical setting.
PMID: 29460410
ISSN: 1520-7560
CID: 2963622
Comparative effectiveness of personalized treatment and usual care for small renal tumors: A decision analysis [Meeting Abstract]
Kang, S K; Huang, W C; Elkin, E B; Braithwaite, R S
Purpose: To compare the effectiveness of standard treatment using partial nephrectomy and personalized management strategies for small renal tumors using a simulation model.
Material(s) and Method(s): A decision-analytic model was constructed to compare life expectancy of management strategies for small renal tumors using: (1) uniform treatment with partial nephrectomy; or personalized options incorporating (2) percutaneous ablation; (3) biopsy, with triage of renal cell carcinoma (RCC) to nephron-sparing therapy; (4) watchful waiting for growth; and (5) MRI-based selection of papillary RCC for watchful waiting. The model included patient age, gender, chronic kidney disease (CKD) stage, renal functional decline specific to treatment type, comorbidities, benign and malignant tumors, RCC subtypes, and differential risks of cancer progression. Decisionmaking based on histologic subtype from biopsy was tested in sensitivity analysis.
Result(s): Partial nephrectomy was favored in patients of all ages with normal renal function. Otherwise, personalized strategies improved life expectancy compared with partial nephrectomy. The favorability of personalized therapy depended upon CKD stage, tumor anatomy and comorbidities. For example, patients with CKD stages 2 or 3a and moderate or high tumor anatomic complexity were most effectively treated with MRI-based management when they had no comorbidities (+ 2.57 years for MRI vs. partial nephrectomy in CKD 3a, Nephrometry Score 10), but with Charlson Comorbidity Index >=1, biopsy or watchful waiting for growth were most effective. Biopsy-based management became most effective in multiple patient subcategories when histologic subtype guided treatment selection.
Conclusion(s): Personalized treatment selection for small renal tumors likely improves life expectancy for patients with abnormal renal function
EMBASE:623203493
ISSN: 2366-0058
CID: 3554202
Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders
Fleisher, Jori; Barbosa, William; Sweeney, Meghan M; Oyler, Sarah E; Lemen, Amy C; Fazl, Arash; Ko, Mia; Meisel, Talia; Friede, Naomi; Dacpano, Geraldine; Gilbert, Rebecca M; Di Rocco, Alessandro; Chodosh, Joshua
Parkinson's disease (PD) is a complex, multisymptom, neurodegenerative disease affecting primarily older adults. With progression, many individuals become homebound and removed from coordinated, expert care, resulting in excess morbidity, mortality, and healthcare expenditures in acute care settings and institutions. Home visit care models have achieved the triple aim of improving individual and population health while reducing costs in many frail, community-dwelling geriatric cohorts. This study details a novel, interdisciplinary home visit program specifically designed for individuals with PD and related disorders and their family caregivers built upon best practice principles in the care of multimorbid older adults. At each quarterly home visit, a movement disorders-trained neurologist, social worker, and nurse work in parallel with the individual and caregiver to complete a history, physical, detailed medication reconciliation, psychosocial needs assessment, and home safety assessment. A comprehensive, person-centered plan is agreed upon, referrals to community resources are made, standardized documentation is shared, and follow-up communication is instituted. In the first 2 years, 272 visits were conducted with 85 individuals who represent one of the oldest, most disabled PD populations reported. Satisfaction with and retention in the program were high. This study represents the first translation of the success of interdisciplinary and home-based geriatric care models to a population with a specific neurological disease. Preliminary evidence supports the need for such programs in vulnerable populations. Future studies will prospectively assess person-centered outcomes, the effect of using telemedicine on sustainability, and cost effectiveness.
PMCID:6105368
PMID: 29608779
ISSN: 1532-5415
CID: 3025272
Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression
Tin, Adrienne; Nadkarni, Girish; Evans, Anne M; Winkler, Cheryl A; Bottinger, Erwin; Rebholz, Casey M; Sarnak, Mark J; Inker, Lesley A; Levey, Andrew S; Lipkowitz, Michael S; Appel, Lawrence J; Arking, Dan E; Coresh, Josef; Grams, Morgan E
PMCID:6050937
PMID: 29777021
ISSN: 1533-3450
CID: 5100992
Sexual Orientation Differences in Modifiable Risk Factors for Cardiovascular Disease and Cardiovascular Disease Diagnoses in Men
Caceres, Billy A; Brody, Abraham A; Halkitis, Perry N; Dorsen, Caroline; Yu, Gary; Chyun, Deborah A
PURPOSE/OBJECTIVE:Despite higher rates of modifiable risk factors for cardiovascular disease (CVD) in gay and bisexual men, few studies have examined sexual orientation differences in CVD among men. The purpose of this study was to examine sexual orientation differences in modifiable risk factors for CVD and CVD diagnoses in men. METHODS:A secondary analysis of the National Health and Nutrition Examination Survey (2001-2012) was conducted. Multiple imputation was performed for missing values. Differences across four distinct groups were analyzed: gay-identified men, bisexual-identified men, heterosexual-identified men who have sex with men (MSM), and heterosexual-identified men who denied same-sex behavior (categorized as exclusively heterosexual). Multiple logistic regression models were run with exclusively heterosexual men as the reference group. RESULTS:The analytic sample consisted of 7731 men. No differences between heterosexual-identified MSM and exclusively heterosexual men were observed. Few differences in health behaviors were noted, except that, compared to exclusively heterosexual men, gay-identified men reported lower binge drinking (adjusted odds ratio [AOR] 0.58, 95% confidence interval [CI] = 0.37-0.85). Bisexual-identified men had higher rates of mental distress (AOR 2.39, 95% CI = 1.46-3.90), obesity (AOR 1.69, 95% CI = 1.02-2.72), elevated blood pressure (AOR 2.30, 95% CI = 1.43-3.70), and glycosylated hemoglobin (AOR 3.01, 95% CI = 1.38-6.59) relative to exclusively heterosexual men. CONCLUSIONS:Gay-identified and heterosexual-identified MSM demonstrated similar CVD risk to exclusively heterosexual men, whereas bisexual-identified men had elevations in several risk factors. Future directions for sexual minority health research in this area and the need for CVD and mental health screenings, particularly in bisexual-identified men, are highlighted.
PMCID:6034400
PMID: 29889585
ISSN: 2325-8306
CID: 3162142
Prostate cancer and social media
Loeb, Stacy; Katz, Matthew S; Langford, Aisha; Byrne, Nataliya; Ciprut, Shannon
The use of social media is increasing globally and is employed in a variety of ways in the prostate cancer community. In addition to their use in research, advocacy, and awareness campaigns, social media offer vast opportunities for education and networking for patients with prostate cancer and health-care professionals, and many educational resources and support networks are available to patients with prostate cancer and their caregivers. Despite the considerable potential for social media to be employed in the field of prostate cancer, concerns remain - particularly regarding the maintenance of patient confidentiality, variable information quality, and possible financial conflicts of interest. A number of professional societies have, therefore, issued guidance regarding social media use in medicine. Social media are used extensively in other cancer communities, particularly among patients with breast cancer, and both the quantity and type of information available are expected to grow in the future.
PMID: 29643501
ISSN: 1759-4820
CID: 3194642
Opioid Overdose Protocols in the Emergency Department: Are We Asking the Right Questions? [Editorial]
Doran, Kelly M; Raja, Ali S; Samuels, Elizabeth A
PMID: 29929652
ISSN: 1097-6760
CID: 3157682
Adapting and Evaluating a Health System Intervention From Kaiser Permanente to Improve Hypertension Management and Control in a Large Network of Safety-Net Clinics
Fontil, Valy; Gupta, Reena; Moise, Nathalie; Chen, Ellen; Guzman, David; McCulloch, Charles E; Bibbins-Domingo, Kirsten
BACKGROUND:Nearly half of Americans with diagnosed hypertension have uncontrolled blood pressure (BP) while some integrated healthcare systems, such as Kaiser Permanente Northern California, have achieved control rates upwards 90%. METHODS AND RESULTS:<0.01). CONCLUSIONS:Evidence-based system approaches to improving BP control can be implemented in safety-net settings and could play a pivotal role in achieving improved population BP control and reducing hypertension disparities.
PMCID:6071320
PMID: 30002140
ISSN: 1941-7705
CID: 5234122
Relationship between tobacco cessation and mental health outcomes in a tobacco cessation trial
Krebs, Paul; Rogers, Erin; Smelson, David; Fu, Steven; Wang, Binhuan; Sherman, Scott
Persons with mental health diagnoses use tobacco at alarming rates, yet misperceptions remain about the effect of quitting on mental health outcomes. This article examines the relationship between tobacco cessation and changes in severity of mental illness. Participants were N = 577 veterans with a history of mental health treatment enrolled in a tobacco cessation study. The effects of abstinence and time on Behavior and Symptom Identification Scale-24 summary scores and subscales were examined. Abstinence at both 2 and 6 months post-baseline was related (p < .0001) to lower Behavior and Symptom Identification Scale-24 summary scores and improvement on three Behavior and Symptom Identification Scale-24 subscales. Providers should recommend and provide tobacco treatment to all mental health patients to improve their physical and mental health functioning.
PMID: 27151069
ISSN: 1461-7277
CID: 2101272
Public online reporting from a nationwide population-based clinical prostate cancer register [Letter]
Stattin, Pär; Sandin, Fredrik; Loeb, Stacy; Robinson, David; Lissbrant, Ingela Franck; Lambe, Mats
PMCID:6032877
PMID: 29577561
ISSN: 1464-410x
CID: 3041072